Effect of Omalizumab (Xolair) on Basophils in Patients With Chronic Idiopathic Urticaria

NCT01701583 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Chronic Urticaria

Interventions

DRUG: Omalizumab

Sponsor

University of Colorado, Denver

Collaborators

[object Object]